Home ›
Trademark Categories ›
Pharmaceuticals ›
2003 ›
PE ›
PEVITER
Trademark search for:
PEVITER
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2003-08-28 — Application filed
2004-03-16 — Assigned to examiner
2004-03-17 — Final disposition recorded
2004-09-20 — Paper received
2004-09-20 — Correspondence received in law office
2004-11-09 — Amendment from applicant entered
2004-11-14 — Office action issued
2004-11-15 — Office action issued
2005-03-10 — Paper received
2005-03-10 — Correspondence received in law office
2005-03-25 — Amendment from applicant entered
2005-03-28 — Final disposition recorded
2005-03-28 — Action denying req for recon mailed
2005-07-08 — Paper received
2005-07-08 — Petition to revive-received
2005-08-23 — Petition to revive-granted
2005-08-24 — Examiners amendment -written
2005-08-25 — Examiners amendment mailed
2005-08-26 — Examiner's amendment entered
2005-08-27 — Approved for pub - principal register
2005-09-09 — Assigned to lie
2005-09-16 — Law office publication review completed
2005-10-19 — Notice of publication
2005-11-08 — Published for opposition
2006-01-31 — Registered-principal register
2012-09-28 — Cancelled sec. 8 (6-yr)
2012-09-28 — Final status recorded
Owner Information
Pevion Biotech Ltd.
Bern CH
Pevion Biotech Ltd.
Bern CH
Pevion Biotech Ltd.
Bern CH
Correspondent
ROBERT C FABER OSTROLENK, FABER, GERB & SOFTEN, LLP 1180 AVE OF THE AMERICAS FL 7 NEW YORK, NY 10036-8443 UNITED STATES
Filing Details
Filing Date:
2003-08-28
Status Date:
2012-09-28
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.